Status:
COMPLETED
Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy
Lead Sponsor:
Yonsei University
Conditions:
Familial Hypertrophic Cardiomyopathy
Eligibility:
All Genders
13+ years
Brief Summary
Set the Korean Familial Hypertrophic Cardiomyopathy (KFHC) registry to study the prevalence of gene mutations in Korean patients with familial hypertrophic cardiomyopathy
Eligibility Criteria
Inclusion
- left ventricular maximal wall thickness ≥ 15mm on echocardiography
- hypertrophic cardiomyopathy patients' relatives
Exclusion
- other cardiomyopathy or systemic disease (e.g. fabry disease, danon disease, glycogen storage disease)
- who deny the study entrance, especially in patients' relatives
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT01792960
Start Date
February 1 2013
End Date
August 1 2013
Last Update
February 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine
Seoul, Seoul, South Korea, 120-752